Neuroprotective strategies in radical prostatectomy

BJU International

Volumn 95, Issue 1, 2005, Pages 11-14

  Schiff, Jonathan D ^a   Mulhall, John P ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Erectile dysfunction; Nerve grafts; Neuroregeneration; Neurostimulation; Radical prostatectomy

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; IMMUNOPHILIN; NEUROPROTECTIVE AGENT; TACROLIMUS;

CANADA; ERECTILE DYSFUNCTION; HUMAN; KOREA; MEDICAL ASSESSMENT; NERVE GRAFT; NERVE INJURY; NERVE REGENERATION; NERVE STIMULATION; NEUROPROTECTION; NONHUMAN; PERCEPTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; ROBOTICS; SHORT SURVEY; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; CAVERNOSAL NERVE; INTRAOPERATIVE PERIOD; NERVE FUNCTION; NERVE TRANSPLANTATION; NEUROMODULATION; PENIS; PENIS ERECTION; PERIPHERAL NERVE; SURAL NERVE; SURGEON;

HUMANS; MALE; NERVE TRANSFER; NERVOUS SYSTEM DISEASES; NEUROTRANSMITTER AGENTS; PENIS; PROSTATECTOMY; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 12544250712     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05239.x     Document Type: Short Survey

References (41)

1. Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll PR. Predictors of treatment after initial surveillance in men with cancer of the prostate: results from CaPSURE. J Urol 2003; 170: 2279-83
2. Walsh PC, Donker PJ. Impotence following radical prostatectomy. insight into etiology and prevention. J Urol 1982; 128: 492-97
3. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433-8
4. Rabbani F, Stapleton AMF, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J. Urol 2000; 164: 1929-34
5. Walsh PC, Marschke P, Ricker D, Burnett AL. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 2000; 55: 58-61
6. Begg CBRE, Riedel ER, Bach PB et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002; 346: 1138-44
7. Jonler M, Messing EM, Rhodes PR, Bruskewitz RC. Sequelae of radical prostatectomy. Br J Urol 1994; 74: 352-58
8. Fowler FJ Jr, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (Updated June 1993). Urology 1993; 42: 622-9
9. Siegel R, Moul JW, Spevak M, Alvord WG, Costabile RA. The development of erectile dysfunction in men treated for prostate cancer. J Urol 2001; 165: 430-5
10. Talcott JA, Rieker P, Clark JA et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol 1998; 16: 275-83
11. Leandri P, Rossignol G, Gautier JR, Ramon J. Radical retropubic prostatectomy: morbidity and quality of life. Experience with 620 consecutive cases. J Urol 1992; 147: 883-7
12. Raina R, Lakin MM, Agarwal A et al. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003; 62: 110-5
13. Zippe CD, Jhaveri FM, Klein EA et al. Role of Viagra after radical prostatectomy. Urology 2000; 55: 241-5
14. Zippe CD, Kedia AW, Kedia K, Nelson DR, Agarwal A. Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology 1998; 52: 963-6
15. Walsh PC, Partin AW, Epstein JL. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994; 152: 1831-6
16. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991; 145: 998-1002
17. Myers RP. Radical prostatectomy: pertinent surgical anatomy. Urol Clin North Am 1994; 2: 1-18
18. Lue TF, Gleason CA, Brock GB, Carroll PR, Tanagho EA. Intra-operative electrostimulation of the cavernous nerve: technique, results and limitations. J Urol 1995; 154: 1426-8
19. Watson DL, Richie JP, Vickers MA et al. Cavernosal nerve stimulation during radical retropubic prostatectomy. J Urol 1995; 153: 383A
20. Klotz L, Herschorn S. Early experience with intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy. Urology 1998; 52: 537-42
21. Klotz L, Heaton J, Jewett M et al. A randomized phase 3 study of intraoperative cavernous nerve stimulation with penile tumescence monitoring to improve nerve sparing during radical prostatectomy. J Urol 2000; 164: 1573-8
22. Kim HL, Stoffel DS, Mhoon DA, Brendler, CB. A positive CaverMap response poorly predicts recovery of potency after radical prostatectomy. Urology 2000; 56: 561-4
23. Chang SS, Peterson M, Smith JA Jr. Intraoperative nerve stimulation predicts postoperative potency. Urology 2001; 58: 594-7
24. Walsh PC, Marschke P, Catalona WJ et al. Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons. Urology 2001; 57: 491-4
25. Scardino PT, Kim ED. Rationale for and results of nerve grafting during radical prostatectomy. Urology 2001; 57: 1016-9
26. Quinlan DM, Nelson RJ, Walsh PC. Cavernous nerve grafts restore erectile function in denervated rats. J Urol 1991; 145: 380-3
27. Ball RA, Richie JP, Vickers MA Jr. Correction of surgically induced erectile dysfunction in the rat by microsurgical interposition nerve graft repair of the cavernosal nerves. Am Coll Surg Forum 1990; 16: 678
28. Ball RA, Lipton SA, Dreyer EB, Richie JP, Vickers MA. Entubulization repair of severed cavernous nerves in the rat resulting in return of erectile function. J Urol 1992; 148: 211-5
29. Burgers JK, Nelson RJ, Quinlan DM, Walsh PC. Nerve growth factor, nerve grafts and amniotic membrane grafts restore erectile function in rats. J Urol 1991; 146: 463-8
30. Kim ED, Scardino PT, Hampel O, Mills NL, Wheeler TM, Nath RK. Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. J Urol 1999; 161: 188-92
31. Kim ED, Nath R, Slawin KM, Kadmon D, Miles BJ, Scardino PT. Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up. Urology 2001; 58: 983-7
32. McKiernan JM, Ohori M, Gerigh C et al. Cavernous nerve graft reconstruction following radical prostatectomy in 77 patients: feasibility, safety and early results. Program and abstracts of the 96th Annual Meeting of the American Urological Association; June 2-7 2001. Anaheim, California. Abstract 613
33. Kim ED, Nath R, Kadmon D et al. Bilateral nerve grafts during radical retropubic prostatectomy: a one year follow-up. J Urol 2001; 165: 1950-6
34. Burnett AL. Neuroprotection and nerve grafts in the treatment of neurogenic erectile dysfunction. J Urol 2003; 170: S31-4
35. Te AE, Santarosa RP, Koo HP et al. Neurotrophic factors in the rat penis. J Urol 1994; 152: 2167-72.
36. Dahiya R, Chui R, Perinchery G, Nakijima K, Oh BR, Lue TF. Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int J Impot Res 1999; 11: 201-6
37. Sezen SF, Hoke A, Burnett AL, Snyder SH. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat Med 2001; 7: 1073-4
38. Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A. FK 506 for liver, kidney, and pancreas transplantation. Lancet 1989; 2: 1000-4
39. Snyder SH, Sabatini DM, Lai MM, Steiner JP, Hamilton GS, Suzdak PD. Neural actions of immunophilin ligands. Trends Pharmacol Sci 1998; 19: 21-6
40. Sezen SF, Blackshaw S, Steiner JP, Burnett AL. FK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injury. Int J Impot Res 2002; 14: 506-12
41. Burnett AL, Becker RE. Immunophilin ligands promote penile neurogenesis and erection recovery after cavernous nerve injury. J Urol 2004; 171: 595-0